Skip to main content
Log in

Overhauling the reimbursement system for molecular diagnostics

  • Correspondence
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Schulman, K.A. & Tunis, S.R. Nat. Biotechnol. 28, 1157–1159 (2010).

    Article  CAS  Google Scholar 

  2. Meckley, L.M. & Neumann, P.J. Health Policy 94, 91–100 (2010).

    Article  Google Scholar 

  3. Trosman, J.R., Van Bebber, S.L. & Phillips, K.A. J. Oncol. Pract. 6, 238–242 (2010).

    Article  Google Scholar 

  4. Anonymous. The New Science of Personalized Medicine: Translating the Promise into Practice (PricewaterhouseCoopers, 2009).

  5. Mohr, P.E. & Tunis, S.R. Pharmacoeconomics 28, 153–162 (2010).

    Article  Google Scholar 

  6. Tunis, S.R. & Pearson, S.D. Health Aff. 25, 1218–1230 (2006).

    Article  Google Scholar 

  7. Atkinson, W. The impact of CED on private payers. Biotechnology Healthcare 24–30 (April 2007).

  8. Kaiser Family Foundation. Kaiser Slides: Medicare Enrolment, 1966–2010 <http://facts.kff.org/chart.aspx?ch=1714> (Accessed 26 January 2011).

  9. Filmore, D. & Bylander, J. The Gray Sheet (28 June 2010).

    Google Scholar 

  10. PricewaterhouseCoopers. Diagnostics 2009: Moving Towards Personalised Medicine (PricewaterhouseCoopers, 2009).

  11. The Lewin Group. The Value of Diagnostics Innovation, Adoption and Diffusion into Health Care (The Lewin Group, 2005).

  12. Allison, M. Nat. Biotechnol. 26, 509–517 (2008).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nafees N Malik.

Ethics declarations

Competing interests

N.N.M. presently works for GlaxoSmithKline, but the correspondence is based on work done at the University of Cambridge.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malik, N. Overhauling the reimbursement system for molecular diagnostics. Nat Biotechnol 29, 390–391 (2011). https://doi.org/10.1038/nbt.1869

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.1869

  • Springer Nature America, Inc.

This article is cited by

Navigation